Choose the service that’s right
for YOU.

Features
Ancestry + Traits
Service
$99

Health + Ancestry
Service
$199

23andMe plus
Membership
$199 $169 +
$29/year
Extended payment options available. Learn more.
Total Reports
80+
150+
Ancestry
Now with 2000+ regions Ancestry Reports
Feature included
Feature included
Feature included
DNA Relative Finder (opt in)
Find and connect with relatives in the 23andMe database who share DNA with you.
Feature included
Feature included
Feature included
Automatic Family Tree Builder
Start a family tree automatically based on your DNA.
Feature included
Feature included
Feature included
Enhanced ancestry features
Get advanced filtering for DNA Relative Finder and access up to 3500 more DNA relatives.
Feature not included
Feature not included
Feature included
Health
Health Predisposition Reports*
10+ reports including: BRCA1/BRCA2 (Selected Variants), Late-Onset Alzheimer's Disease, Type 2 Diabetes ( Powered by 23andMe Research )
Feature not included
Feature included
Feature included
Carrier Status Reports*
40+ reports including: Cystic Fibrosis, Sickle Cell Anemia, Hereditary Hearing Loss
Feature not included
Feature included
Feature included
Wellness Reports
5+ reports including: Deep Sleep, Lactose Intolerance, Genetic Weight
Feature not included
Feature included
Feature included
Family Health History Tree NEW!
Easily input, track and download your family health history to share with your healthcare provider.
Feature not included
Feature included
Feature included
Pharmacogenetics reports**
Discover how your DNA may impact how your body processes certain medications with three new Pharmacogenetics reports.
Feature not included
Feature not included
Feature included
Traits
Trait Reports
30+ traits including: Male Bald Spot, Sweet vs. Salty, Unibrow
Feature included
Feature included
Feature included
Other
Share, compare and discover more with friends and family
Trace DNA through your close family and explore the genetic similarities and differences between you and family members.
Ancestry + Traits
Reports only
All
Reports
All
Reports
Add Health Predisposition*, Carrier Status*, and Wellness reports
Add later
for $125***
Included!
Included!
Ongoing new reports and features
Get exclusive new reports and enhanced features automatically delivered throughout the calendar year.
Feature not included
Feature not included
Feature included
$99

$199

$199 $169 +
$29/year
Extended payment options available. Learn more.

*The 23andMe PGS test includes health predisposition and carrier status reports. Health predisposition reports include both reports that meet FDA requirements for genetic health risks and the 23andMe Type 2 Diabetes health predisposition report which is based on 23andMe research and has not been reviewed by FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. Warnings & Limitations: The 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants) is indicated for reporting of the 185delAG and 5382insC variants in the BRCA1 gene and the 6174delT variant in the BRCA2 gene. The report describes if a woman is at increased risk of developing breast and ovarian cancer, and if a man is at increased risk of developing breast cancer or may be at increased risk of developing prostate cancer. The three variants included in this report are most common in people of Ashkenazi Jewish descent and do not represent the majority of BRCA1/BRCA2 variants in the general population. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact cancer risk. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitations regarding each genetic health risk and carrier status report, visit 23andme.com/test-info/

**23andMe PGS Pharmacogenetics reports: The 23andMe test uses qualitative genotyping to detect 6 variants in 3 genes in the genomic DNA of adults from saliva for the purpose of reporting and interpreting information about the processing of certain therapeutics to inform discussions with a healthcare professional. It does not describe if a person will or will not respond to a particular therapeutic and does not describe the association between detected variants and any specific therapeutic. Results should be confirmed by an independent genetic test that is prescribed by your own healthcare professional before taking any medical action. Warning: Test information should not be used to start, stop, or change any course of treatment and does not test for all possible variants that may affect metabolism or protein function. The PGS test is not a substitute for visits to a healthcare professional. Making changes to your current regimen can lead to harmful side effects or reduced intended benefits of your medication, therefore consult with your healthcare professional before taking any medical action. For a complete list of the 6 variants tested, visit https://permalinks.23andme.com/pdf/pgt_product_info_page_21jan2020.pdf

***Savings based on regular upgrade price of $125. We may offer special discounted upgrades from time to time.

Choose the service that’s right for YOU.

Ancestry + Traits
$99

order
Health + Ancestry
$199

order
23andMe plus Membership
$199 $169 +
$29/year
order
Extended payment options available. Learn more.
Total Reports
80+
150+
Your DNA can tell you about your family history. Ancestry Composition, Ancestry Detail Reports, Maternal & Paternal Haplogroups, Neanderthal Ancestry
Feature included
Feature included
Feature included
Find and connect with relatives in the 23andMe database who share DNA with you.
Feature included
Feature included
Feature included
Start a family tree automatically based on your DNA.
Feature included
Feature included
Feature included
Get advanced filtering for DNA Relative Finder and access up to 3500 more DNA relatives.
Feature not included
Feature not included
Feature included
10+ reports including: BRCA1/BRCA2 (Selected Variants), Celiac Disease, Late-Onset Alzheimer's Disease, Type 2 Diabetes ( Powered by 23andMe Research )
Feature not included
Feature included
Feature included
If you are starting a family, find out if you are a carrier for an inherited condition. Example reports include: Cystic Fibrosis, Sickle Cell Anemia, Hereditary Hearing Loss
Feature not included
Feature included
Feature included
Learn how your genes play a role in your well-being and lifestyle choices. Example reports include: Deep Sleep, Lactose Intolerance, Genetic Weight
Feature not included
Feature included
Feature included
Easily input, track and download your family health history to share with your healthcare provider.
Feature not included
Feature included
Feature included
Discover how your DNA may impact how your body processes certain medications with three new Pharmacogenetics reports.
Feature not included
Feature not included
Feature included
Explore what makes you unique, from food preferences to physical features. Example reports include: Male Bald Spot, Sweet vs. Salty, Unibrow
Feature included
Feature included
Feature included
Get exclusive new reports and enhanced features automatically delivered throughout the calendar year.
Feature not included
Feature not included
Feature included
Ancestry + Traits
$99

order
Health + Ancestry
$199

order
23andMe plus Membership
$199 $169 +
$29/year
order
Extended payment options available. Learn more.

*The 23andMe PGS test includes health predisposition and carrier status reports. Health predisposition reports include both reports that meet FDA requirements for genetic health risks and the 23andMe Type 2 Diabetes health predisposition report which is based on 23andMe research and has not been reviewed by FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. Warnings & Limitations: The 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants) is indicated for reporting of the 185delAG and 5382insC variants in the BRCA1 gene and the 6174delT variant in the BRCA2 gene. The report describes if a woman is at increased risk of developing breast and ovarian cancer, and if a man is at increased risk of developing breast cancer or may be at increased risk of developing prostate cancer. The three variants included in this report are most common in people of Ashkenazi Jewish descent and do not represent the majority of BRCA1/BRCA2 variants in the general population. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact cancer risk. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitations regarding each genetic health risk and carrier status report, visit 23andme.com/test-info/

**23andMe PGS Pharmacogenetics reports: The 23andMe test uses qualitative genotyping to detect 6 variants in 3 genes in the genomic DNA of adults from saliva for the purpose of reporting and interpreting information about the processing of certain therapeutics to inform discussions with a healthcare professional. It does not describe if a person will or will not respond to a particular therapeutic and does not describe the association between detected variants and any specific therapeutic. Results should be confirmed by an independent genetic test that is prescribed by your own healthcare professional before taking any medical action. Warning: Test information should not be used to start, stop, or change any course of treatment and does not test for all possible variants that may affect metabolism or protein function. The PGS test is not a substitute for visits to a healthcare professional. Making changes to your current regimen can lead to harmful side effects or reduced intended benefits of your medication, therefore consult with your healthcare professional before taking any medical action. For a complete list of the 6 variants tested, visit https://permalinks.23andme.com/pdf/pgt_product_info_page_21jan2020.pdf